相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Signaling mechanisms underlying the insulin-sensitizing effects of adiponectin
Kenneth K. Y. Cheng et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
UPLC-MSE application in disease biomarker discovery: The discoveries in proteomics to metabolomics
Ying-Yong Zhao et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Metabolomics Reveals Broad-Scale Metabolic Perturbations in Hyperglycemic Mothers During Pregnancy
Denise M. Scholtens et al.
DIABETES CARE (2014)
Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice
Jillian L. Rourke et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Steven E. Kahn et al.
LANCET (2014)
An atlas of genetic influences on human blood metabolites
So-Youn Shin et al.
NATURE GENETICS (2014)
Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis
Phillip J. White et al.
NATURE MEDICINE (2014)
Irisin as a muscle-derived hormone stimulating thermogenesis - A critical update
Tobias Hofmann et al.
PEPTIDES (2014)
Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies
Norbert Stefan et al.
PLOS ONE (2014)
Adiponectin signaling in the liver
Terry P. Combs et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)
Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus
Isabel Moreno-Indias et al.
FRONTIERS IN MICROBIOLOGY (2014)
Adiponectin and its receptors: implications for obesity-associated diseases and longevity
Takashi Kadowaki et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Adipokines - removing road blocks to obesity and diabetes therapy
Matthias Blueher
MOLECULAR METABOLISM (2014)
Inventing new medicines: The FGF21 story
Alexei Kharitonenkov et al.
MOLECULAR METABOLISM (2014)
FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases
Nobuyuki Itoh
FRONTIERS IN ENDOCRINOLOGY (2014)
Adipokines and insulin action A sensitive issue
Alexander J. Knights et al.
ADIPOCYTE (2014)
Application of combined omics platforms to accelerate biomedical discovery in diabesity
Irwin J. Kurland et al.
ANNALS MEETING REPORTS (2013)
Application of Metabolomics to Diagnosis of Insulin Resistance
Michael V. Milburn et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A
Tae Woo Jung et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The Gut Microbiotassay: a high-throughput qPCR approach combinable with next generation sequencing to study gut microbial diversity
Marie Louise Hermann-Bank et al.
BMC GENOMICS (2013)
Adiponectin Receptor as a Key Player in Healthy Longevity and Obesity-Related Diseases
Toshimasa Yamauchi et al.
CELL METABOLISM (2013)
Adiponectin Mediates the Metabolic Effects of FGF21 on Glucose Homeostasis and Insulin Sensitivity in Mice
Zhuofeng Lin et al.
CELL METABOLISM (2013)
An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
William L. Holland et al.
CELL METABOLISM (2013)
Fibroblast Growth Factor 21 as an emerging metabolic regulator: clinical perspectives
Y. C. Woo et al.
CLINICAL ENDOCRINOLOGY (2013)
Adiponectin Corrects High-Fat Diet-Induced Disturbances in Muscle Metabolomic Profile and Whole-Body Glucose Homeostasis
Ying Liu et al.
DIABETES (2013)
High Glucose Represses β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets Involvement of Peroxisome Proliferator-Activated Receptor γ Signaling
Wing Yan So et al.
DIABETES (2013)
Assessing the Human Gut Microbiota in Metabolic Diseases
Fredrik Karlsson et al.
DIABETES (2013)
Added value of novel circulating and genetic biomarkers in type 2 diabetes prediction: A systematic review
Justin B. Echouffo-Tcheugui et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Serum irisin levels in new-onset type 2 diabetes
Yeon-Kyung Choi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?
S. Kralisch et al.
DIABETOLOGIA (2013)
Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome
Kyung Hee Park et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: A 3-year prospective study in China
Huating Li et al.
JOURNAL OF HEPATOLOGY (2013)
A Combined Epidemiologic and Metabolomic Approach Improves CKD Prediction
Eugene P. Rhee et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Miki Okada-Iwabu et al.
NATURE (2013)
The role of hepatokines in metabolism
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Adipo-Myokines: Two Sides of the Same Coin-Mediators of Inflammation and Mediators of Exercise
Silja Raschke et al.
MEDIATORS OF INFLAMMATION (2013)
Branched chain amino acids are novel biomarkers for discrimination of metabolic wellness
Bryan C. Batch et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Towards an integrative approach to understanding the role of chemerin in human health and disease
J. L. Rourke et al.
OBESITY REVIEWS (2013)
The Human Gut Chip HuGChip'', an Explorative Phylogenetic Microarray for Determining Gut Microbiome Diversity at Family Level
William Tottey et al.
PLOS ONE (2013)
Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines
Elaine Hui et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
Adiponectin, driver or passenger on the road to insulin sensitivity?
Risheng Ye et al.
MOLECULAR METABOLISM (2013)
Modulating the human gut microbiome as an emerging therapeutic paradigm
Deepak K. Rajpal et al.
SCIENCE PROGRESS (2013)
Metabolomic profiling as a useful tool for diagnosis and treatment of chronic disease: focus on obesity, diabetes and cardiovascular diseases
Oh Yoen Kim et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2013)
The central role of myostatin in skeletal muscle and whole body homeostasis
B. Elliott et al.
ACTA PHYSIOLOGICA (2012)
Tissue-Specific Insulin Signaling, Metabolic Syndrome, and Cardiovascular Disease
Christian Rask-Madsen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Human serum proteome analysis: new source of markers in metabolic disorders
Francesco Di Girolamo et al.
BIOMARKERS IN MEDICINE (2012)
Therapeutic Perspectives for Adiponectin: an Update
F. Y.L. Li et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps
Charmaine S. Tam et al.
DIABETES CARE (2012)
Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
Pedro Iglesias et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Introducing GUt Low-Density Array (GULDA) - a validated approach for qPCR-based intestinal microbial community analysis
Anders Bergstrom et al.
FEMS MICROBIOLOGY LETTERS (2012)
Relationship of Serum Fibroblast Growth Factor 21 with Abnormal Glucose Metabolism and Insulin Resistance: The Baltimore Longitudinal Study of Aging
Richard D. Semba et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Distinct Changes in Serum Fibroblast Growth Factor 21 Levels in Different Subtypes of Diabetes
Yang Xiao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Is irisin a human exercise gene?
James A. Timmons et al.
NATURE (2012)
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Pontus Bostroem et al.
NATURE (2012)
Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Durba Pal et al.
NATURE MEDICINE (2012)
Muscles, exercise and obesity: skeletal muscle as a secretory organ
Bente K. Pedersen et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
Joo Young Huh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines
S. E. Park et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2012)
Serum Retinol-Binding Protein 4 as a Marker for Cardiovascular Disease in Women
Khalid M. Alkharfy et al.
PLOS ONE (2012)
Biomarkers and immune-modulating therapies for Type 2 diabetes
Barbara Brooks-Worrell et al.
TRENDS IN IMMUNOLOGY (2012)
Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome
D. Margriet Ouwens et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2012)
Chemerin: a potential endocrine link between obesity and type 2 diabetes
Alexandra A. Roman et al.
ENDOCRINE (2012)
ADIPOCYTE FATTY ACID BINDING PROTEIN AND C-REACTIVE PROTEIN LEVELS AS INDICATORS OF INSULIN RESISTANCE DEVELOPMENT
Dagmar Horakova et al.
BIOMEDICAL PAPERS-OLOMOUC (2011)
Comparison between C-reactive protein and adipocyte fatty acid-binding protein as a component of metabolic syndrome in middle-aged women
Anna Stefanska et al.
CLINICAL BIOCHEMISTRY (2011)
High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes A 5.4-year population-based prospective study in Chinese subjects
Cheng Chen et al.
DIABETES CARE (2011)
Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
Fredirick L. Mashili et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease
H. O. El-Mesallamy et al.
DIABETIC MEDICINE (2011)
Serum FGF-21 Levels in Type 2 Diabetic Patients
Xingbo Cheng et al.
ENDOCRINE RESEARCH (2011)
RBP4: a controversial adipokine
Primoz Kotnik et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Investigation of Myostatin Serum Levels Before and After a 6-Month Lifestyle Intervention Program in Obese Children
S. Ehehalt et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2011)
Relations of Adiponectin to Levels of Metabolic Parameters and Sexual Hormones in Elderly Type 2 Diabetic Patients
Sazan Rasul et al.
GENDER MEDICINE (2011)
Gut microbiome, obesity, and metabolic dysfunction
Herbert Tilg et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity
Hong Lan et al.
JOURNAL OF LIPID RESEARCH (2011)
Adiponectin Action: A Combination of Endocrine and Autocrine/Paracrine Effects
Keith Dadson et al.
Frontiers in Endocrinology (2011)
IL-6 selectively stimulates fat metabolism in human skeletal muscle
Emil Wolsk et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
The genetics of type 2 diabetes: what have we learned from GWAS?
Liana K. Billings et al.
YEAR IN DIABETES AND OBESITY (2010)
Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes
Johanna Weigert et al.
CLINICAL ENDOCRINOLOGY (2010)
Obesity, Diabetes, and Gut Microbiota The hygiene hypothesis expanded?
Giovanni Musso et al.
DIABETES CARE (2010)
Serum Fetuin-A is an Independent Marker of Insulin Resistance in Japanese Men
Ayako Ishibashi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Adipocyte Fatty Acid-binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-terminal Kinases and Activator Protein-1
Xiaoyan Hui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease: The Roles of Fetuin-A, Adiponectin, and AMPK
Joachim H. Ix et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Next-generation biomarkers for detecting kidney toxicity
Joseph V. Bonventre et al.
NATURE BIOTECHNOLOGY (2010)
Myostatin Decreases with Aerobic Exercise and Associates with Insulin Resistance
Dustin S. Hittel et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2010)
Combined Impact of Adiponectin and Retinol-binding Protein 4 on Metabolic Syndrome in Elderly People: The Korean Longitudinal Study on Health and Aging
Soo Lim et al.
OBESITY (2010)
Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes
Anke Toenjes et al.
PLOS ONE (2010)
Secreted proteins from adipose tissue and skeletal muscle – adipokines, myokines and adipose/muscle cross-talk
Paul Trayhurn et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2010)
Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients
Fatma Ülgen et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2010)
Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis
Yusuf Yilmaz et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt
Michael R. Morissette et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment
Ying Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance
Christopher B. Newgard et al.
CELL METABOLISM (2009)
Recent Advances in Molecular Approaches to Gut Microbiota in Inflammatory Bowel Disease
Akira Andoh et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Increased Secretion and Expression of Myostatin in Skeletal Muscle From Extremely Obese Women
Dustin S. Hittel et al.
DIABETES (2009)
Loss-of-Function Mutation in Myostatin Reduces Tumor Necrosis Factor α Production and Protects Liver Against Obesity-Induced Insulin Resistance
Jason J. Wilkes et al.
DIABETES (2009)
Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells
Henrike Sell et al.
DIABETES (2009)
Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
Alberto O. Chavez et al.
DIABETES CARE (2009)
Relationships Between Circulating Metabolic Intermediates and Insulin Action in Overweight to Obese, Inactive Men and Women
Kim M. Huffman et al.
DIABETES CARE (2009)
Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population
Kiymet Bozaoglu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Interleukin-1β induces the novel adipokine chemerin in adipocytes in vitro
Susan Kralisch et al.
REGULATORY PEPTIDES (2009)
Post-translational modifications of adiponectin: mechanisms and functional implications
Yu Wang et al.
BIOCHEMICAL JOURNAL (2008)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice
Mathieu Membrez et al.
FASEB JOURNAL (2008)
FGF21 attenuates lipolysis in human adipocytes -: A possible link to improved insulin sensitivity
Peter Arner et al.
FEBS LETTERS (2008)
Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes
Michiko Takahashi et al.
FEBS LETTERS (2008)
Fetuin-A and incident diabetes mellitus in older persons
Joachim H. Ix et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
βKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c
Masashi Suzuki et al.
MOLECULAR ENDOCRINOLOGY (2008)
Systems biology - Metabonomics
Jeremy K. Nicholson et al.
NATURE (2008)
A-FABP - A biomarker associated with the metabolic syndrome and/or an indicator of weight change?
Julia Engl et al.
OBESITY (2008)
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
Anita M. Hennige et al.
PLOS ONE (2008)
Adipocyte fatty acid-binding protein in obese children before and after weight loss
Thomas Reinehr et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people
Qibin Qi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor
Miriam Promintzer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects
Ying Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Chemerin is a novel adipokine associated with obesity and metabolic syndrome
Kiymet Bozaoglu et al.
ENDOCRINOLOGY (2007)
Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women
Matthias Moehlig et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
βKlotho is required for metabolic activity of fibroblast growth factor 21
Yasushi Ogawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome - A 5-year prospective study
Aimin Xu et al.
CIRCULATION (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes
Young Min Cho et al.
DIABETES CARE (2006)
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
Andrew L. Carey et al.
DIABETES (2006)
Association between human fetuin-A and the metabolic syndrome - Data from the Heart and Soul Study
JH Ix et al.
CIRCULATION (2006)
α2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans
N Stefan et al.
DIABETES CARE (2006)
Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1α-mediated NF-κB activation and down-regulation of TRAF2 expression
P Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells
C Weigert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
AM Xu et al.
CLINICAL CHEMISTRY (2006)
Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects
K Mori et al.
DIABETES CARE (2006)
The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism
A Chmurzynska
JOURNAL OF APPLIED GENETICS (2006)
Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance
BQ Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades
BA Zabel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang et al.
NATURE (2005)
Role of myostatin in metabolism
NF Gonzalez-Cadavid et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2004)
Metabolic and molecular basis of insulin resistance
M Bajaj et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2003)
Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism
O Tschritter et al.
DIABETES (2003)
Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
ED Abel et al.
NATURE (2001)
Genomewide search for type 2 diabetes-susceptibility genes in French whites:: Evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24
N Vionnet et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans
A Katz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
分享论文
